임상시험 트래커
추적 기업 30곳의 임상 6,982건 (국내 전체 이력 · 글로벌 진행 중). 출처: ClinicalTrials.gov
기업
60건 표시 (상위 60건)
- 3상모집 예정· Limited Stage Small-Cell Lung Cancer제한기 소세포폐암 치료: 타를라타맙과 듀르발루맙 병합 vs. 듀르발루맙 단독
Tarlatamab and Durvalumab vs. Durvalumab Alone for Limited-Stage-Small Cell Lung Cancer
협력: 암젠
- 3상모집 예정· Autoimmune HepatitisA Trial of Inebilizumab in Participants With Autoimmune Hepatitis
리드: 암젠
- 2상모집 중· Generalized Myasthenia GravisA Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Inebilizumab in Children With Generalized Myasthenia Gravis (gMG)
리드: 암젠
- 2상모집 예정· Immunoglobulin G4-related DiseaseStudy to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Inebilizumab in Pediatric Participants With IgG4-RD
리드: 암젠
- 3상모집 예정· Primary Immune ThrombocytopeniaA Study of Romiplostim Plus Predniso(lo)ne vs. Predniso(lo)ne Alone for the Treatment of Previously Untreated Primary Immune Thrombocytopenia (ITP)
리드: 암젠
- 2상모집 예정· Acute Lymphoblastic Leukemia (ALL) Philadelphia Chromosome-positive (Ph+)Subcutaneous Blinatumomab Plus Ponatinib for BCR-ABL+ B-ALL
협력: 암젠
- 2/3상모집 예정· Granulomatosis With PolyangiitisTAVNEOS for Otolaryngologic Manifestations of Granulomatosis With Polyangiitis
협력: 암젠
- 1상모집 중· Diabetes Mellitus, Type 2A Trial Evaluating AMG 127 in Healthy Participants and Participants With Type 2 Diabetes Mellitus
리드: 암젠
- 3상모집 예정· Philadelphia Chromosome Negative B-cell Precursor Acute Lymphoblastic LeukemiaA Study Evaluating Subcutaneous Versus Intravenous Blinatumomab in Newly Diagnosed Adults With B-cell Precursor Acute Lymphoblastic Leukaemia
리드: 암젠
- 1/2상모집 예정· B-cell Acute Lymphoblastic LeukemiaA Study of Inotuzumab and Blinatumomab in People With B-cell Acute Lymphoblastic Leukemia
협력: 암젠, 화이자
- 3상모집 중· Neovascular Age-related Macular DegenerationA Study to Evaluate Efficacy, Safety, and Immunogenicity With ABP 938 8 mg Versus EYLEA® HD (Aflibercept) in Participants With Neovascular Age-related Macular Degeneration
리드: 암젠
- 2상모집 중· Thyroid Eye DiseaseAn Open-label, Rollover Trial to Evaluate the Efficacy and Safety of AMG 732 in Participants With Thyroid Eye Disease
리드: 암젠
- 해당없음모집 예정· Atherosclerotic Cardiovascular Disease (ASCVD)Health Enhanced Artery Risk Tracking With Widespread Implementation and Screening Effort in ASCVD (HEARTWISE-ASCVD)
협력: 암젠
- 1상모집 중· Metastatic Castration-resistant Prostate Cancer (mCRPC)Trial of Xaluritamig in Adults With Metastatic Castration-resistant Prostate Cancer
리드: 암젠
- 1상모집 중· Small Cell Lung CancerStudy of Tarlatamab + ZL-1310 +/- Anti-programmed Death Ligand 1 (Anti-PD-L1) in Small Cell Lung Cancer (SCLC)
리드: 암젠
- 단계 미표기모집 중· Neuromyelitis Optica Spectrum DisorderObservational Safety Study in Women With Neuromyelitis Optica Spectrum Disorder (NMOSD) Exposed to UPLIZNA® During Pregnancy
리드: 암젠
- 2상모집 중· Extensive Stage Lung Small Cell CancerA Trial of Tarlatamab in Patients With Pretreated Extensive-stage Small Cell Lung Cancer (ES-SCLC) and ECOG PS 2
협력: 암젠
- 1상모집 중· Metastatic or Locally Advanced Solid Tumors With Microsatellite Instability-high (MSI-H) or Mismatched Repair Deficiency (dMMR)AMG 436 as Monotherapy and Combination Therapy in Participants With MSI-H/dMMR Solid Tumors
리드: 암젠
- 단계 미표기모집 예정· Neuromyelitis Optica Spectrum DisordersAnticipating Irreversible Disability in Neuromyelitis Optica Spectrum Disorder: a Study to Assess Disease Activity in Apparently Stable Patients
협력: 암젠
- 3상모집 중· Cardiovascular DiseaseOlpasiran Trials of Cardiovascular Events and Lipoprotein(a) Reduction - Coronary Computed Tomography Angiography Trial
리드: 암젠
- 2상모집 중· Extensive Stage Lung Small Cell CarcinomaTarlatamab for the Treatment of Extensive Stage Small-cell Lung Cancer
협력: 암젠
- 3상모집 중· Osteogenesis ImperfectaPediatric Safety Follow-up Study of Prior Treatment With Romosozumab for Osteogenesis Imperfecta
리드: 암젠
- 2상모집 중· Overweight or Obesity and Elevated Liver FatA Trial to Evaluate Efficacy and Safety of Maridebart Cafraglutide in Adults Living With Elevated Liver Fat and Obesity or Overweight
리드: 암젠
- 2상모집 중단 (진행 중)· B-cell Acute Lymphoblastic LeukemiaA Phase 2 Study to Assess the Safety and Efficacy of Subcutaneous Blinatumomab in Combination With Low Intensity Chemotherapy in Older Patients With Newly Diagnosed B-cell Acute Lymphoblastic Leukemia
협력: 암젠
- 1상모집 중단 (진행 중)· Healthy ParticipantsComparing the Extent to Which Two Evolocumab Drug Products Are Made Available in the Body After a Single Subcutaneous Dose
리드: 암젠
- 2상모집 중· Advanced Solid TumorsA Rollover Study Evaluating Sotorasib With or Without Panitumumab in Participants With KRAS p.G12C Mutation
리드: 암젠
- 2상모집 중· Advanced Neuroendocrine Carcinomas of The Digestive SystemRefractory Advanced diGestive Neuroendocrine Carcinomas Treated With tARlatamab
협력: 암젠
- 1/2상모집 중단 (진행 중)· Relapsed/Refractory B-Cell Precursor Acute Lymphoblastic LeukemiaA Study of Subcutaneous Blinatumomab in Children With R/R and and MRD+ B-Cell Precursor Acute Lymphoblastic Leukemia
리드: 암젠
- 3상모집 중· Metastatic Castration-resistant Prostate CancerA Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
리드: 암젠
- 1상모집 중단 (진행 중)· OverweightEffect of Maridebart Cafraglutide on the Heart's Electrical Activity
리드: 암젠
- 1상모집 중· Metastatic Hormone-sensitive Prostate Cancer (mHSPC)Study Evaluating the Safety, Tolerability, and Efficacy of Xaluritamig in Combination With Androgen Receptor Pathway Inhibitors in Participants With Metastatic Hormone-sensitive Prostate Cancer
리드: 암젠
- 1상모집 중· Extensive Stage Small Cell Lung CancerA Study of Tarlatamab in Combination With AB248 in Participants With Extensive Stage Small Cell Lung Cancer (DeLLphi-311)
리드: 암젠
- 1/2상모집 중· MelanomaRadiation Combined With BIspecific T-Cell Engager in DLL3 Expressing Tumors
협력: 암젠
- 3상모집 중· Small-cell Lung CancerA Study Comparing Tarlatamab, Durvalumab, Carboplatin, and Etoposide Versus Durvalumab, Carboplatin, and Etoposide in First-line Extensive Stage Small-Cell Lung Cancer (ES-SCLC)
리드: 암젠 · 협력: 아스트라제네카
- 1상모집 중단 (진행 중)· Type 2 Diabetes MellitusA Study to Evaluate the Effect of Maridebart Cafraglutide on Insulin Sensitivity and β-cell Function in Participants With Type 2 Diabetes Mellitus
리드: 암젠
- 1상모집 중· KRAS Altered Advanced or Metastatic Solid TumorsAMG 410 Alone and in Combination With Other Agents in Participants With KRAS Altered Advanced or Metastatic Solid Tumors
리드: 암젠
- 3상모집 중· Atherosclerotic Cardiovascular DiseaseEvaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
리드: 암젠
- 2상모집 중· Systemic Lupus ErythematosusA Phase 2 Master Protocol Assessing Inebilizumab and Blinatumomab in Autoimmune Diseases
리드: 암젠
- 2상모집 중· Metastatic/Locally Advanced Small-Cell Lung CancerStudy Investigating Tarlatamab (AMG 757) in Patients With Metastatic/Locally Advanced Small-Cell Lung Cancer (SCLC) and Other Poorly Differentiated Neuroendocrine Carcinomas (NECs), With Biomarker Analysis to Characterize Response/Resistance (UNLOCK TARLATAMAB)
협력: 암젠
- 3상모집 중· Heart Failure With Preserved Ejection FractionMaridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
리드: 암젠
BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.